studies
ciliary
dyskinesia
factor
cystic
fibrosis
iv
possible
identification
anaphylatoxin
c
igg
complex
presumptive
evidence
indicates
substance
responsible
pathophysiologic
conditions
cystic
fibrosis
cf
complement
component
c
also
known
anaphylatoxin
known
biochemical
physiological
properties
c
together
behavior
purified
substance
associated
igg
tracheal
bioassay
compare
favorably
molecular
species
separated
sera
cell
cultures
cf
homozygotes
heterozygotes
sera
normal
healthy
subjects
previously
inactive
bioassay
ciliary
dyskinesia
factor
cdf
converted
cdf
positive
state
incubation
epsilon
amino
caproic
acid
eaca
eaca
known
inhibitor
carboxypeptidase
b
like
anaphylatoxin
inactivator
method
choice
accumulating
anaphylatoxins
normal
blood
incubation
eaca
treated
normal
sera
two
fresh
cdf
positive
cf
sera
carboxypeptidase
b
produced
reversion
instances
cdf
negative
normal
state
proposed
anaphylatoxin
inactivator
carboxypeptidase
b
like
enzyme
defective
deficientin
cystic
fibrosis
deficiency
primary
gene
defect
